Related Experiment Video

Updated: May 2, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

13.8K

Immunology: TREG cells in transplantation-a double-edged sword?

Fadi G Lakkis1

  • 1Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, BST-W1548, 200 Lothrop Street, Pittsburgh, PA 15261, USA.

Nature Reviews. Nephrology
|March 12, 2014
PubMed

Insights

Regulatory T cells in the blood directly correlate with invasive skin cancer risk in kidney transplant patients. Higher regulatory T cell counts indicate a greater likelihood of developing skin cancer after transplantation.

Area of Science:

  • Immunology
  • Oncology
  • Transplantation Medicine

Background:

  • Immunosuppressive drugs are vital for preventing organ rejection and managing autoimmune diseases.
  • These medications are linked to a higher risk of developing various cancers.
  • Understanding cancer risk factors in transplant recipients is crucial for patient care.

Purpose of the Study:

  • To investigate the association between regulatory T cell counts and invasive skin cancer incidence.
  • To identify specific immune markers that predict skin cancer risk in kidney transplant recipients.

Main Methods:

  • Analysis of blood samples from kidney transplant recipients.
  • Quantification of regulatory T cell populations.
  • Correlation of T cell counts with documented cases of invasive skin cancer.

Main Results:

  • A direct relationship was observed between the number of regulatory T cells and the risk of invasive skin cancer.
  • Increased regulatory T cell levels were associated with a higher incidence of skin cancer in this cohort.

Conclusions:

  • Regulatory T cells may play a significant role in the development of skin cancer post-transplantation.
  • Monitoring regulatory T cell counts could aid in stratifying skin cancer risk in kidney transplant patients.

More Related Videos

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

5.3K
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

15.5K

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
64.7K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
13.7K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
3.7K